In the area of specialty pharmacy services, the Kaiser-Evernorth agreement seeks to deliver overall value and savings to Kaiser Permanente and its commercial plan members
Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, recently announced it was selected as a limited distribution partner for VYVGART
Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies
The FDA has accepted for Priority Review the supplemental New Drug Application (sNDA) for voxelotor (Oxbryta®) for the treatment of sickle cell disease in patients aged 4 to 11 years
The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy
Accredo is the only specialty pharmacy (SP) that prepares and ships Evrysdi directly to patients each month. Evrysdi is not available at retail pharmacies
AnovoRx’s focus is intentionally centered on the unique needs of patients with chronic diseases who rely on specialty and orphan drugs as well as manufacturers
Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers